Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) EBT Margin (2021 - 2025)

Historic EBT Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 22518.6%.

  • Pulse Biosciences' EBT Margin changed N/A to 22518.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 86876.74%, marking a year-over-year change of. This contributed to the annual value of 8357.86% for FY2022, which is 38684400.0% down from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' EBT Margin is 22518.6%.
  • In the past 5 years, Pulse Biosciences' EBT Margin registered a high of 102188.89% during Q4 2022, and its lowest value of 22518.6% during Q3 2025.
  • Over the past 3 years, Pulse Biosciences' median EBT Margin value was 3189.23% (recorded in 2021), while the average stood at 11133.32%.
  • The largest annual percentage gain for Pulse Biosciences' EBT Margin in the last 5 years was 1040154300bps (2022), contrasted with its biggest fall of 1040154300bps (2022).
  • Quarter analysis of 3 years shows Pulse Biosciences' EBT Margin stood at 1826.54% in 2021, then soared by 5695bps to 102188.89% in 2022, then plummeted by -122bps to 22518.6% in 2025.
  • Its EBT Margin stands at 22518.6% for Q3 2025, versus 102188.89% for Q4 2022 and 4665.33% for Q2 2022.